Crossmark

Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study

Crossref DOI link: https://doi.org/10.1245/s10434-021-10983-2

Published Online: 2021-10-28

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kepenekian, Vahan

Péron, Julien

You, Benoit

Bonnefoy, Isabelle

Villeneuve, Laurent

Alyami, Mohammad

Bakrin, Naoual

Rousset, Pascal

Benzerdjeb, Nazim

Glehen, Olivier
License Information

Text and Data Mining valid from 2021-10-28

Version of Record valid from 2021-10-28
More Information

Article History

Received: 14 June 2021

Accepted: 8 September 2021

First Online: 28 October 2021

Disclosure

: Olivier Glehen is a consultant for Gamida. The French network for the treatment of rare peritoneal malignancies (RENAPE) was sponsored by the French National Cancer Institute (INCa). There are no conflicts of interest.

Document is current

Any future updates will be listed below